Intel stock surged 15% in two days after joining Elon Musk's Terafab project. But the market is pricing in the best case. Here's what the Terafab deal actually means for Intel's foundry business, its 18A process node, and whether the stock is a buy at $59. Our full financial analysis, price targets, and bull/bear case are available to BMInsider PRO members below.
Intel stock surged 15% in two days after joining Elon Musk's Terafab project. But the market is pricing in the best case. Here's what the Terafab deal actually means for Intel's foundry business, its 18A process node, and whether the stock is a buy at $59.
Our full financial analysis, price targets, and bull/bear case are available to BMInsider PRO members below.
[membership level="2,5,6,7"]
What Is Terafab?
Terafab is Elon Musk's plan to build the world's largest semiconductor fabrication facility. The project unites Tesla, SpaceX, and xAI under one manufacturing roof — producing custom AI chips at a scale that doesn't exist yet. Intel is the manufacturing partner.
Why Intel?
TSMC is the obvious choice for chip fabrication, but there's a geopolitical problem: Taiwan. The U.S. government wants domestic chip production, and Intel is the only American company with leading-edge foundry capability. The 18A process node — Intel's most advanced technology — is what attracted Musk.
The Numbers
| Terafab estimated investment | $50B+ |
| Intel foundry revenue (2025) | $1.2B |
| Intel total capex | $25B annually |
| TSMC capex (2025) | $32B |
| Intel price before Terafab | $47 |
| Intel price after Terafab | $59 (+25%) |
Bull Case
$85
18A works as promised. Foundry revenue hits $10B by 2028. CHIPS Act subsidies cover 30% of costs.
Bear Case
$35
18A has yield problems. Terafab delays push costs higher. TSMC remains dominant.
Our Verdict
Intel at $59 is pricing in Terafab success but not perfection. The risk/reward is attractive for a 2–3 year hold. We rate Intel a BUY with a $72 target and a SELL below $42.
Disclaimer: This analysis is for informational purposes only and does not constitute investment advice. The author may hold positions in securities mentioned.
[/membership]
[membership level="-2,-5,-6,-7"]
This is BMInsider PRO content
You're reading a Deep Dive — our most in-depth research.
Unlock full access to all analyses, Smart Money breakdowns & more.
Unlock BMInsider PRO →
✓ Cancel anytime
✓ $9.49/month
✓ Instant access
[/membership]
